RAPT Therapeutics News

Wolfe Downgrades RAPT, but Still Sees "Immense" Upside Potential

Seeking AlphaMay 14 15:06 ET

Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform

RAPT Therapeutics (RAPT) has an average rating of outperform and price targets ranging from $4 to $33, according to analysts polled by Capital IQ.

MT NewswiresMay 14 07:08 ET

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)

TipRanksMay 14 04:40 ET

Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation

Yahoo FinanceMay 12 09:18 ET

RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview

Yahoo FinanceMay 10 15:46 ET

RAPT Falls for Second Day as Guggenheim, Barclays Downgrade Stock

Seeking AlphaMay 10 10:50 ET

Maintaining Hold Rating on RAPT Therapeutics Amid Clinical Uncertainties and Financial Outlook

TipRanksMay 10 06:49 ET

Express News | RAPT Therapeutics Inc : Guggenheim Cuts to Neutral Rating

ReutersMay 10 06:33 ET

Express News | Guggenheim Downgrades RAPT Therapeutics to Neutral

BenzingaMay 10 06:29 ET

RAPT Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 — Guggenheim Downgrades Buy → Neutral 04/10/2024 — HC Wainwright & Co. Reiterates → Neutral 0

BenzingaMay 10 06:28 ET

Express News | RAPT Therapeutics Inc : Barclays Cuts to Equal Weight From Overweight; Cuts Target Price to $4 From $13

ReutersMay 10 06:24 ET

US Equity Markets Close Higher Thursday as Jobless Claims Climb

US equity markets ended higher Thursday as initial jobless claims increased more than expected. * Initial jobless claims rose by 22,000 to 231,000 in the week ended May 4 from an upwardly revised 209,

MT NewswiresMay 9 16:05 ET

Sector Update: Health Care

Health care stocks rose late Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each gaining 0.8%. The iShares Biotechnology ETF (IBB) rose 0.7%. In c

MT NewswiresMay 9 15:33 ET

RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials

RAPT Therapeutics (RAPT) shares plunged more than 40% in recent Thursday trading after the drugmaker reported a wider loss in Q1 and closed its clinical trials of zelnecirnon in atopic dermatitis and

MT NewswiresMay 9 14:31 ET

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?

On Thursday, RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind both its Phase 2b trial of zelnecirnon (RPT193) in atopic dermatitis (AD) and its Phase 2a trial of

BenzingaMay 9 14:12 ET

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results.Duolingo reported quarterly earnings of 57 cents per share whic

BenzingaMay 9 13:57 ET

RAPT Therapeutics Shares Hit 52-Week Low After Trials Closed

By Chris Wack RAPT Therapeutics shares hit their 52-week low of $4.39 after the company shut down two Phase 2 trials. The stock was trading down 41% at $4.67 on Thursday, and was down 76% in the pas

WSJMay 9 12:49 ET

12 Health Care Stocks Moving In Thursday's Intraday Session

GainersEmbecta (NASDAQ:EMBC) shares increased by 37.7% to $14.14 during Thursday's regular session. The company's market cap stands at $814.1 million. As per the press release, Q2 earnings came out to

BenzingaMay 9 12:31 ET

Express News | RAPT Therapeutics Shares Are Trading Lower. The Company Reported Q1 Financial Results

BenzingaMay 9 11:11 ET

Tivic Health, RAPT Therapeutics, Notable Labs Among Healthcare Movers

Seeking AlphaMay 9 10:00 ET